Who Should Be Investigated for Haematuria? Results of a Contemporary Prospective Observational Study of 3556 Patients

This study highlights the requirement to investigate all patients with visible blood in the urine and an age threshold of ≥60 yr, as recommended in some guidelines, as the investigation of nonvisible blood in the urine will miss a significant number of urinary tract cancers. Patient preference is important, and evidence that patients are willing to submit to investigation should be considered in reaching a consensus recommendation for the investigation of haematuria. International consensus to guide that patients will benefit from investigation should be developed.
Source: European Urology - Category: Urology & Nephrology Source Type: research